Loading...
Aurobindo Pharma Limited — Cefuroxime Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Cefuroxime · $26.5M export value · DGFT Verified
Aurobindo Pharma Limited is the #4 Indian exporter of Cefuroxime with $26.5M in export value and 266 verified shipments. Aurobindo Pharma Limited holds a 14.3% market share in Cefuroxime exports across 16 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.9M | 265 | 33.9% |
| MALTA | $5.6M | 380 | 27.8% |
| BRAZIL | $2.2M | 94 | 11.1% |
| MALAYSIA | $1.7M | 57 | 8.2% |
| SOUTH AFRICA | $794.2K | 31 | 3.9% |
| CANADA | $761.7K | 22 | 3.8% |
| UNITED STATES OF AMERICA | $678.3K | 18 | 3.3% |
| FRANCE | $265.7K | 21 | 1.3% |
| CROATIA | $244.0K | 9 | 1.2% |
| IRAQ | $186.9K | 10 | 0.9% |
Aurobindo Pharma Limited exports Cefuroxime to 28 countries. The largest destination is UNITED STATES accounting for 33.9% of Aurobindo Pharma Limited's Cefuroxime shipments, followed by MALTA (27.8%) and BRAZIL (11.1%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES MALTA LTD | MALTA | $2.2M | 110 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $1.3M | 109 |
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $1.2M | 45 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $1.1M | 52 |
| NORTHSTAR DISTRIBUTION CENTER 8912 |
India exported $82.9M worth of Cefuroxime through 6,961 shipments from 440 suppliers to 150 countries, serving 1,458 buyers globally. Aurobindo Pharma Limited contributes $26.5M to this total, accounting for 14.3% of India's Cefuroxime exports. Aurobindo Pharma Limited ships Cefuroxime to 28 countries through 103 buyers.
Aurobindo Pharma Limited's average Cefuroxime shipment value is $99.7K per consignment, based on 266 shipments totaling $26.5M. The largest destination is UNITED STATES (33.9% of Aurobindo Pharma Limited's Cefuroxime exports).
Aurobindo Pharma Limited ranks #4 among 440 Indian Cefuroxime exporters with a 14.3% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($18.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($16.8M), ALKEM LABORATORIES LIMITED ($11.6M). Aurobindo Pharma Limited processed 266 shipments to 16 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEFUROXIME AXETIL TABLETS 500MG (CEFUROX | $1.8M | 54 |
| CEFUROXIME AXETIL TABLETS 500MG (Cefurox | $812.3K | 27 |
| CEFUROXIME AXETIL TABLETS 500MG(CEFUROXI | $478.0K | 23 |
| CEFUROXIME AXETIL TABLETS 500MG (CEFUROXIME AXETIL TABLETS 500 MG) | $464.8K | 11 |
| CEFUROXIME AXETIL TABLETS 250MG (CEFUROX | $396.3K | 26 |
| CEFUROXIME AXETIL TABLETS 500MG(Cefuroxi | $357.4K | 10 |
| CEFUROXIME AXETIL TABLETS 500MG CEFUROXIM PUREN 500 MG FTA | $257.4K | 8 |
| CEFUROXIME AXETIL TABLETS 500MG(AURO-CEF | $221.0K | 5 |
| CEFUROXIME AXETIL TABLETS 500MG (CEFUROXIME AXETIL TABLETS 500 MG)NOS |
What Aurobindo Pharma Limited must comply with to export Cefuroxime to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $16.8M | 336 | 9 | $50.0K |
| 3 | ALKEM LABORATORIES LIMITED | $11.6M | 231 | 14 | $50.0K |
| 4 | AUROBINDO PHARMA LIMITED ★ | $8.0M | 266 | 16 | $30.1K |
| 5 | THEON PHARMACEUTICALS LIMITED | $7.5M |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 10.2% |
| SAHAR AIR | 670 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 661 | 9.5% |
| HYDERABAD ICD | 316 | 4.5% |
| DELHI AIR | 312 | 4.5% |
| DELHI AIR CARGO ACC (INDEL4) | 300 | 4.3% |
| JNPT/ NHAVA SHEVA SEA | 281 | 4.0% |
| HYDERABAD ICD (INSNF6) | 278 | 4.0% |
Aurobindo Pharma Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Cefuroxime, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cefuroxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Cefuroxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
| UNITED STATES |
| $976.5K |
| 45 |
| BRAINFARMA INDUSTRIA QUIMICA E FARM | BRAZIL | $932.3K | 35 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $906.6K | 22 |
| AUROBINDO PHARMA USA INC | UNITED STATES | $728.0K | 25 |
| RISING PHARMA HOLDINGS INC | UNITED STATES | $561.1K | 16 |
| APL SWIFT SERVICES (MALTA) LIMITED | MALTA | $543.9K | 37 |
Aurobindo Pharma Limited supplies Cefuroxime to 103 buyers globally. The largest buyer is APL SWIFT SERVICES MALTA LTD (MALTA), followed by APL SWIFT SERVICES (MALTA) LTD., (MALTA) and AUROBINDO PHARMA USA., INC, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $211.1K |
| 9 |
| CEFUROXIME AXETIL TABLETS 250MG (CEFUROXIME AXETIL TABLETS 250 MG) | $201.5K | 11 |
Aurobindo Pharma Limited exports 484 distinct Cefuroxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFUROXIME AXETIL TABLETS 500MG (CEFUROX with 54 shipments worth $1.8M.
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 586 |
| 8 |
| $12.7K |
| 6 | NECTAR LIFE SCIENCES LIMITED | $4.0M | 120 | 17 | $33.4K |
Aurobindo Pharma Limited ranks #4 among 440 Indian Cefuroxime exporters. Average shipment value of $30.1K compared to the market average of $188.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and ALKEM LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefuroxime. For current shipment-level data, contact TransData Nexus.